A Novel Anti‑EGFR Monoclonal Antibody (EMab‑17) Exerts Antitumor Activity Against Oral Squamous Cell Carcinomas via Antibody‑dependent Cellular Cytotoxicity and Complement‑dependent Cytotoxicity

Oncology Letters - Greece
doi 10.3892/ol.2020.11384
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications